TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
OGN

Organon & Co

Healthcare · Drug Manufacturers - General

13.70$ -0.3% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Balance Sheet

Organon & Co (OGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 12,867 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet OGN
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
– 10,494 10,548 10,109 10,681 10,955 12,058 13,101 12,867
– 3,714 3,955 3,567 3,760 3,931 4,508 4,348 4,352
– 244 319 12 737 706 693 675 574
– 244 319 12 737 706 693 675 574
– 1,593 1,573 1,405 1,512 1,606 1,857 1,491 1,433
– 994 1,071 913 915 1,003 1,315 1,321 1,406
– 651 762 1,089 973 1,233 1,356 1,325 1,458
– 4,603 4,603 4,603 4,603 4,603 4,603 4,680 4,153
– 812 569 503 651 649 533 1,414 1,130
– 4,146 3,513 4,623 12,189 11,847 12,128 12,629 12,115
– 1,545 1,341 2,673 2,597 2,512 2,918 2,718 2,390
– -207 48 8.0 55 57 55 64 56
– 289 258 259 1,382 1,132 1,314 1,153 952
– 34 70 0.0 9,125 8,905 8,751 8,860 8,628
– 6,348 7,035 5,486 -1,508 -892 -70 472 752
– – 0.0 -219 -998 -331 443 1,010 1,109
253 253 253 254 254 255 256 259 261

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?